This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

dermatology

Adherence to NICE criteria for biologic treatment in atopic dermatitis
Adherence to NICE criteria for biologic treatment in atopic dermatitis
Older adults with atopic eczema at greater risk of developing Alzheimer’s disease
Older adults with atopic eczema at greater risk of developing Alzheimer’s disease
NICE approves Cosentyx for children and young people with psoriasis
NICE approves Cosentyx for children and young people with psoriasis
EU approves bimekizumab for moderate to severe psoriasis
EU approves bimekizumab for moderate to severe psoriasis
Upadacitinib superior at clearing atopic eczema compared with dupilumab
Upadacitinib superior at clearing atopic eczema compared with dupilumab
Network meta-analysis confirms superiority of biologics to small molecules in plaque psoriasis
Network meta-analysis confirms superiority of biologics to small molecules in plaque psoriasis
Fumaric acid esters effective in children with moderate to severe psoriasis
Fumaric acid esters effective in children with moderate to severe psoriasis


Popular articles

Shorter tuberculosis treatment strategy non-inferior to standard regimen
Prostate cancer mortality no different in trial of three treatment interventions
Aggressive end-of-life care more common in nursing home compared to community residents
High-sensitivity CRP superior to LDL cholesterol for CV event and mortality risk prediction
Higher plasma caffeine levels linked to reduced body fat and type 2 diabetes risk according to genetic study




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora